Adeno-associated virus (AAV) gene therapies hold great promise, but ensuring product quality is critical. One major challenge? The presence of empty capsids, which can reduce therapeutic effectiveness. Traditional methods for assessing empty/full ratios are slow and labor-intensive, delaying workflows.
This guide explores a faster, high-throughput approach to accurately evaluate AAV capsid content and help researchers improve efficiency and accelerate gene therapy development.
Inside this technical note, you’ll discover:
- A rapid, high-throughput method for AAV E/F ratio.
- How to efficiently screen crude and purified AAV samples.
- How to achieve accurate results in just 30 minutes.
Download this free technical note to discover how you can streamline your AAV analysis.